Our sessions focused on identifying the prodromal stage of MSA, advancing early diagnosis, exploring biomarkers, and discussing innovative interventions. We presented the latest insights into MSA drug trials, highlighting promising developments as we strengthen our understanding and approach toward combating MSA.
Building on the success of last year’s event, the symposium attracted almost 150 attendees and offered a unique platform to exchange knowledge and network, allowing ideas to be shared, and potential research collaborations explored.
You can view the recording of the Symposium below: